Università Vita-Salute San Raffaele

News: Research

UniSR project funded by AriSLA for research on amyotrophic lateral sclerosis
Research16 January 2024
UniSR project funded by AriSLA for research on amyotrophic lateral sclerosis
An immunotherapy molecule that counteracts chronic hepatitis B tested in preclinical models
Research11 January 2024
An immunotherapy molecule that counteracts chronic hepatitis B tested in preclinical models
ChatGPT tested in giving correct answers on cardiac arrest and cardiopulmonary resuscitation
Medicine12 December 2023
ChatGPT tested in giving correct answers on cardiac arrest and cardiopulmonary resuscitation
A study on anti-tumor T lymphocytes opens up future therapeutic products against acute myeloid leukemia
Research06 December 2023
A study on anti-tumor T lymphocytes opens up future therapeutic products against acute myeloid leukemia
MINE Lab, the laboratory on modular implantable neurotechnologies, is born
Medicine04 December 2023
MINE Lab, the laboratory on modular implantable neurotechnologies, is born
Discovered a key-mechanism in the pathogenesis of pancreatic cancer
Research01 November 2023
Discovered a key-mechanism in the pathogenesis of pancreatic cancer
Research27 October 2023
"Age-It" programme: also UniSR in the largest research hub on ageing
ERC Synergy Grant awarded to UniSR for research on immunotherapy of liver metastases
Awards26 October 2023
ERC Synergy Grant awarded to UniSR for research on immunotherapy of liver metastases
Prof. Luca Guidotti awarded the Distinguished Award in Hepatitis B Research
Awards19 September 2023
Prof. Luca Guidotti awarded the Distinguished Award in Hepatitis B Research
Colorectal cancer: study of the microenvironment opens up new possible immunotherapies
Research18 September 2023
Colorectal cancer: study of the microenvironment opens up new possible immunotherapies
Acute lymphoblastic leukemia: two results from San Raffaele could favor prognosis and therapy
Research15 September 2023
Acute lymphoblastic leukemia: two results from San Raffaele could favor prognosis and therapy
San Raffaele is the only center authorized to administer the medicine against ADA-SCID
Research12 September 2023
San Raffaele is the only center authorized to administer the medicine against ADA-SCID